• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A way forward on the medically appropriate use of white cell growth factors.

作者信息

Smith Thomas J, Hillner Bruce E

机构信息

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD 21287-0005, USA.

出版信息

J Clin Oncol. 2012 May 10;30(14):1584-7. doi: 10.1200/JCO.2011.39.9980. Epub 2012 Feb 27.

DOI:10.1200/JCO.2011.39.9980
PMID:22370327
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3383110/
Abstract
摘要

相似文献

1
A way forward on the medically appropriate use of white cell growth factors.关于合理医学使用白细胞生长因子的前进道路。
J Clin Oncol. 2012 May 10;30(14):1584-7. doi: 10.1200/JCO.2011.39.9980. Epub 2012 Feb 27.
2
The role of mini-allotransplants in the treatment of solid tumors.小型同种异体移植在实体瘤治疗中的作用。
Ann Oncol. 2002;13 Suppl 4:281-6. doi: 10.1093/annonc/mdf671.
3
High-dose chemotherapy for breast cancer.乳腺癌的大剂量化疗。
Cancer Treat Res. 2000;103:77-114. doi: 10.1007/978-1-4757-3147-7_5.
4
Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphoma.大剂量序贯化疗及净化自体造血细胞移植的毒性使其无法用于难治性/复发性非霍奇金淋巴瘤。
Biol Blood Marrow Transplant. 2000;6(5A):555-62. doi: 10.1016/s1083-8791(00)70065-6.
5
[Not Available].[无可用内容]。
Strahlenther Onkol. 2016 Sep;192(9):675-6. doi: 10.1007/s00066-016-1017-5.
6
Status of high-dose chemotherapy for breast cancer: a review.乳腺癌大剂量化疗的现状：综述
Biol Blood Marrow Transplant. 2000;6(5):476-95. doi: 10.1016/s1083-8791(00)70019-x.
7
High-dose ifosfamide/carboplatin/etoposide: maximum tolerable doses, toxicities, and hematopoietic recovery after autologous stem cell reinfusion.大剂量异环磷酰胺/卡铂/依托泊苷：自体干细胞回输后的最大耐受剂量、毒性及造血恢复情况。
Semin Oncol. 1994 Oct;21(5 Suppl 12):86-92.
8
[High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich].[大剂量化疗联合自体骨髓移植：苏黎世11年经验]
Schweiz Med Wochenschr. 2000 Jan 22;130(3):60-9.
9
The impact of induction duration and the number of high-dose cycles on the long-term survival of women with metastatic breast cancer treated with high-dose chemotherapy with stem cell rescue: an analysis of sequential phase I/II trials from the Dana-Farber/Beth Israel STAMP program.诱导期持续时间和高剂量周期数对接受含干细胞救援的高剂量化疗的转移性乳腺癌女性长期生存的影响：来自达纳-法伯/贝斯以色列女执事医疗中心STAMP项目的序贯I/II期试验分析
Biol Blood Marrow Transplant. 2002;8(4):198-205. doi: 10.1053/bbmt.2002.v8.pm12017145.
10
Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.局部放疗和粒细胞-巨噬细胞集落刺激因子引发转移性实体瘤患者的远隔效应：一项原理验证试验。
Lancet Oncol. 2015 Jul;16(7):795-803. doi: 10.1016/S1470-2045(15)00054-6. Epub 2015 Jun 18.

引用本文的文献

1
Patterns of granulocyte colony-stimulating factor prophylaxis in patients with cancer receiving myelosuppressive chemotherapy.癌症患者接受骨髓抑制性化疗时粒细胞集落刺激因子预防的模式。
Support Care Cancer. 2020 Sep;28(9):4413-4424. doi: 10.1007/s00520-020-05295-2. Epub 2020 Jan 10.
2
Practice Patterns for Older Adult Patients With Advanced Cancer: Physician Office Versus Hospital Outpatient Setting.老年晚期癌症患者的实践模式：医生办公室与医院门诊环境。
J Oncol Pract. 2019 Jan;15(1):e30-e38. doi: 10.1200/JOP.18.00315. Epub 2018 Dec 13.
3
Adherence to granulocyte-colony stimulating factor (G-CSF) guidelines to reduce the incidence of febrile neutropenia after chemotherapy--a representative sample survey in Germany.遵循粒细胞集落刺激因子（G-CSF）指南以降低化疗后发热性中性粒细胞减少症的发生率——德国的一项代表性抽样调查
Support Care Cancer. 2016 Jan;24(1):367-376. doi: 10.1007/s00520-015-2779-5. Epub 2015 Jun 17.
4
Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis.接受每日一次非格司亭治疗的患者发生化疗引起的中性粒细胞减少并发症的风险及后果：预防持续时间的重要性。
BMC Health Serv Res. 2014 Apr 27;14:189. doi: 10.1186/1472-6963-14-189.

本文引用的文献

1
Myeloid Growth Factors, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.髓系生长因子，2.2017 年版，NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2017 Dec;15(12):1520-1541. doi: 10.6004/jnccn.2017.0175.
2
Uptake and economic impact of first-cycle colony-stimulating factor use during adjuvant treatment of breast cancer.乳腺癌辅助治疗中首周期集落刺激因子使用的摄取和经济影响。
J Clin Oncol. 2012 Mar 10;30(8):806-12. doi: 10.1200/JCO.2011.37.7499. Epub 2012 Feb 6.
3
Small cell lung cancer.小细胞肺癌
J Natl Compr Canc Netw. 2011 Oct;9(10):1086-113. doi: 10.6004/jnccn.2011.0092.
4
Myeloid growth factors.髓系生长因子
J Natl Compr Canc Netw. 2011 Aug 1;9(8):914-32. doi: 10.6004/jnccn.2011.0075.
5
Advancing performance measurement in oncology.推进肿瘤学中的绩效衡量。
Am J Manag Care. 2011 May;17 Suppl 5 Developing:SP32-6.
6
Use of colony-stimulating factors with chemotherapy: opportunities for cost savings and improved outcomes.化疗联合使用集落刺激因子：节省成本和改善预后的机会。
J Natl Cancer Inst. 2011 Jun 22;103(12):979-82. doi: 10.1093/jnci/djr152. Epub 2011 Jun 13.
7
Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.个性化医疗与癌症支持性护理：化疗中集落刺激因子支持的合理应用。
J Natl Cancer Inst. 2011 Jun 22;103(12):910-3. doi: 10.1093/jnci/djr195. Epub 2011 Jun 13.
8
Cost-effectiveness of granulocyte colony-stimulating factor prophylaxis for febrile neutropenia in breast cancer in the United Kingdom.英国乳腺癌患者发热性中性粒细胞减少症使用粒细胞集落刺激因子预防的成本效益分析。
Value Health. 2011 Jun;14(4):465-74. doi: 10.1016/j.jval.2010.10.037. Epub 2011 Apr 22.
9
Systematic review of efficacy of dose-dense versus non-dose-dense chemotherapy in breast cancer, non-Hodgkin lymphoma, and non-small cell lung cancer.系统评价密集剂量与非密集剂量化疗在乳腺癌、非霍奇金淋巴瘤和非小细胞肺癌中的疗效。
Crit Rev Oncol Hematol. 2012 Mar;81(3):296-308. doi: 10.1016/j.critrevonc.2011.04.010. Epub 2011 Jun 1.
10
Bending the cost curve in cancer care.控制癌症治疗成本
N Engl J Med. 2011 May 26;364(21):2060-5. doi: 10.1056/NEJMsb1013826.